Low-Normal Thyroid Function Is Not Associated with Either Non-Alcoholic Fatty Liver Disease or with Metabolic Dysfunction-Associated Fatty Liver Disease

被引:1
|
作者
Zuarth-Vazquez, Julia [1 ]
Moreno-Castaneda, Lidia [1 ]
Soriano-Marquez, Juan Pablo [2 ]
Velazquez-Aleman, Alain [3 ]
Ramos-Ostos, Martha Helena [4 ]
Uribe, Misael [2 ]
Lopez-Mendez, Ivan [5 ]
Juarez-Hernandez, Eva [3 ]
机构
[1] Med Clin & Fdn, Internal Med Dept, Mexico City 14050, Mexico
[2] Med Clin & Fdn, Gastroenterol & Obes Unit, Mexico City 14050, Mexico
[3] Med Clin & Fdn, Translat Res Unit, Mexico City 14050, Mexico
[4] Med Clin & Fdn, Integral Diag & Treatment Ctr, Mexico City 14050, Mexico
[5] Med Clin & Fdn, Hepatol & Transplants Unit, Mexico City 14050, Mexico
来源
LIFE-BASEL | 2023年 / 13卷 / 04期
关键词
thyroid function; steatosis; metabolic syndrome; controlled attenuation parameter; GLOBAL EPIDEMIOLOGY; RISK; TSH;
D O I
10.3390/life13041048
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: The association of low-normal thyroid function (LNTF) with non-alcoholic fatty liver disease (NAFLD) or metabolic dysfunction-associated fatty liver disease (MAFLD) is controversial; thus, the aim of this study is to determine this association. Methods: NAFLD was evaluated by controlled attenuation parameter of transient elastography. Patients were classified by MAFLD criteria. LNTF was defined as TSH levels of 2.5 to 4.5 mIU/L and were divided into three different cut-off points (>4.5 to 5.0, >3.1, and >2.5 mIU/L). Associations between LNTF, NAFLD, and MAFLD were evaluated by univariate and multivariate logistic regression analyses. Results: A total of 3697 patients were included; 59% (n = 2179) were male, and median age and body mass index were 48 (43-55) years and 25.9 (23.6-28.5) kg/m(2), respectively, and 44% (n = 1632) were diagnosed with NAFLD. THS levels of 2.5 and 3.1 showed significant associations with the presence of NAFLD and MAFLD; however, LNTF did not show an independent association with the presence of NAFLD or MAFLD in multivariate analysis. According to different cut-off points, patients with LNTF presented similar risks for NAFLD as the general population. Conclusion: LNTF is not associated with NAFLD or MAFLD. Patients with high LNTF are equally at risk for NAFLD as the general population.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Thyroid function is associated with non-alcoholic fatty liver disease in euthyroid subjects
    Tao, Yang
    Gu, Hongbing
    Wu, Jingcheng
    Sui, Jian
    ENDOCRINE RESEARCH, 2015, 40 (02) : 74 - 78
  • [22] COMPARISON OF METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE WITH NON-ALCOHOLIC FATTY LIVER DISEASE IN IDENTIFYING CARDIOVASCULAR RISK IN CHINESE INDIVIDUALS WITH RHEUMATOID ARTHRITIS
    Zou, Y. W.
    Li, Q. H.
    Gao, J. W.
    Pan, J.
    Ma, J. D.
    Chen, L. F.
    Lin, J.
    Mo, Y.
    Zhang, X.
    Liu, P. M.
    Dai, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1264 - 1264
  • [23] Muscle strength and non-alcoholic fatty liver disease/metabolic-associated fatty liver disease
    Hao, Xuan-Yu
    Zhang, Kai
    Huang, Xing-Yong
    Yang, Fei
    Sun, Si-Yu
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (07) : 636 - 643
  • [24] Impact of Thyroid Function on the Prevalence and Mortality of Metabolic Dysfunction-Associated Fatty Liver Disease
    Chen, Yu-ling
    Tian, Shen
    Wu, Juan
    Li, Hao
    Li, Shu
    Xu, Zhou
    Liang, Xin-yu
    Adhikari, Vishnu Prasad
    Xiao, Jun
    Song, Jing-yu
    Ma, Chen-yu
    She, Rui-ling
    Li, Zhao-xing
    Wu, Kai-nan
    Kong, Ling-quan
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (07): : E434 - E443
  • [25] Diabetes and metabolic dysfunction-associated fatty liver disease
    Davis, Timothy M. E.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 123
  • [26] Metabolic Dysfunction-associated Fatty Liver Disease is Associated with Greater Impairment of Lung Function than Nonalcoholic Fatty Liver Disease
    Miao, Lei
    Yang, Li
    Guo, Li-Sha
    Shi, Qiang-Qiang
    Zhou, Teng-Fei
    Chen, Yang
    Zhang, Huai
    Cai, Hui
    Xu, Zhi-Wei
    Yang, Shuan-Ying
    Lin, Hai
    Cheng, Zhe
    Zhu, Ming-Yang
    Nan, Xu
    Huang, Shuai
    Zheng, Ya-Wen
    Targher, Giovanni
    Byrne, Christopher D.
    Li, Yu-Ping
    Zheng, Ming-Hua
    Chen, Cheng-Shui
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 10 (02) : 230 - 237
  • [27] From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
    Chen, Li
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (12) : 1253 - 1257
  • [28] Non-alcoholic fatty liver disease may be associated with endothelial dysfunction
    Balta, Sevket
    Demirkol, Sait
    Arslan, Zekeriya
    Demir, Mustafa
    Unlu, Murat
    Kucuk, Ugur
    UPSALA JOURNAL OF MEDICAL SCIENCES, 2014, 119 (01) : 57 - 57
  • [29] Low thyroid function is associated with metabolic dysfunction-associated steatotic liver disease
    Wang, Shuo
    Xia, Ding
    Fan, Hong
    Liu, Zhenqiu
    Chen, Ruilin
    Suo, Chen
    Zhang, Tiejun
    JGH OPEN, 2024, 8 (02):
  • [30] Metabolic dysfunction-associated steatotic liver disease: Where does non-alcoholic fatty liver disease in liver transplant recipients fit in this new definition?
    Choudhary, Narendra Singh
    Dhampalwar, Swapnil
    Saraf, Neeraj
    Soin, Arvinder S.
    JOURNAL OF HEPATOLOGY, 2024, 80 (02) : e77 - e79